Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

Presentation TCT 2024

Imaging Considerations

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

Characterizing Atrial FMR: From Diagnosis to Management Pathways

Presenter: Rebecca Hahn

October 30, 2024

Presentation TCT 2024

Topic 3: TTVR – Avoiding Jail Time – The Issue of RV Leads and Conduction Disorders

Presenter: Rebecca Hahn

October 29, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News NY Valves 2024

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Michael O'Riordan

June 07, 2024

Presentation NY Valves 2024

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

Echocardiographic Characterization

Presenter: Rebecca T. Hahn

June 05, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

Presentation NY Valves 2024

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

Presenter: Rebecca T. Hahn

June 05, 2024

News Conference News ACC 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

L.A. McKeown

April 07, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

Advertisement

Imaging Considerations

Characterizing Atrial FMR: From Diagnosis to Management Pathways

Topic 3: TTVR – Avoiding Jail Time – The Issue of RV Leads and Conduction Disorders

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

AV Block Common After Transcatheter Tricuspid Valve Replacement for TR

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

Echocardiographic Characterization

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Late Clinical Outcomes With Balloon Expandable Valves in Small Annulus Patients From the PARTNER Trials

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content